E. P. Diamandis, MD, Ph.D

Head of Clinical Biochemistry Mount Sinai Hospital

Medical Advisor at imaware™


Dr. Diamandis is using proteomics and mass spectrometry to discover and validate novel biomarkers for diagnosis and monitoring of cancer. He is examining the role of cardiac glycosides and other compounds as novel therapeutics for cancer. He is also investigating novel ways for prenatal diagnosis of Down Syndrome and other fetal abnormalities by using simple tests in maternal blood. Holds the Hold'em for Life Chair in Prostate Cancer Biomarkers. Dr. Diamandis is the Director of the Advanced Center for Detection of Cancer and is working closely with clinicians at the Koffler Center for Urologic Diseases to study prostate cancer and male infertility.


1972-76: B.Sc. Chemistry, University of Athens, Greece
1976-79: Ph.D. Analytical Chemistry, University of Athens, Greece
1978-82: 1984-86 M.D. University of Athens, Greece
1982-84: Clinical Biochemistry Diploma University of Toronto, Canada

View Google Scholar profile


  • Mechanisms of Carcinogenesis and Metastatic Progression
  • Translational Research
  • Cancer Therapeutics
  • Male Infertility
  • Prostate cancer
  • Pathobiology and Biomarkers of Autoimmune Diseases
  • Neurodegeneration
E. P. Diamandis, MD, Ph.D

Recommended By

E. P. Diamandis, MD, Ph.D

No items found.
Our content process